Curis Stock Quote
$9.83 -$0.44 -4.3%
Price as of January 26, 2021, 8:27 p.m. EST View Interactive CRIS Charts

A drug discovery and development company that is seeking to leverage its innovative biological signaling pathway drug technologies to create new medicines primarily in the field of cancer.

Interactive Chart

News & Analysis: Curis


Market Moves

3 Top Stocks Under $5

Cheap stocks are often cheap for a reason, but sometimes the market has mispriced their potential.

This Week in Biotech

A mixed bag of clinical studies, a highly-awaited FDA panel thumbs-up, and an unwelcome subpoena from the Department of Health and Human Services for one biotech company are this week's top stories.

Why Curis Inc. Shares Tanked

Curis shares sink after reporting early-stage clinical data involving CUDC-907. Is now the time to buy, or should shareholders stick to the sidelines?

This Week in Biotech

Two positive clinical studies, a partial clinical hold by the FDA, a scrapped phase 2 study, and an expanded strategic partnership to fight obesity are among this week's top stories in the biotech sector.